Evidence map›Paper›PMID 22550170›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.

María Castañeda-Bueno, Luz Graciela Cervantes-Pérez, Norma Vázquez, Norma Uribe, Sheila Kantesaria, Luciana Morla, Norma A Bobadilla, Alain Doucet, Dario R Alessi, Gerardo Gamba

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 256 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The evolving concepts of KS-WNK1 effect on NCC activity.American journal of physiology. Renal physiology · 2025
    Review
  8. Article
  9. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
  10. Article
  11. Role of calcineurin in regulating renal potassium (KActa physiologica (Oxford, England) · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Current perspective on circadian function of the kidney.American journal of physiology. Renal physiology · 2024
    Review
  16. Arginine vasopressin regulates the renal NaAmerican journal of physiology. Renal physiology · 2024
    Article
  17. Review
  18. Article
  19. The role ofJournal of pharmaceutical analysis · 2023
    Review
  20. Review

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

María Castañeda-BuenoMolecular Physiology Unit, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Tlalpan 14000 Mexico City, Mexico.
Luz Graciela Cervantes-Pérez
Norma Vázquez
Norma Uribe
Sheila Kantesaria
Luciana Morla
Norma A Bobadilla
Alain Doucet
Dario R Alessi
Gerardo Gamba
Universidad Nacional Autónoma de México · MXMetabolism and Renal Physiology · FRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXMRC Protein Phosphorylation and Ubiquitylation Unit · GBPfizer (United States) · US

Funding

Medical Research Council MC_U127070193Wellcome Trust 091415
6 · The paper itself

Abstract

Pseudohypoaldosteronism type II is a salt-sensitive form of hypertension with hyperkalemia in humans caused by mutations in the with-no-lysine kinase 4 (WNK4). Several studies have shown that WNK4 modulates the activity of the renal Na(+)Cl(-) cotransporter, NCC. Because the renal consequences of WNK4 carrying pseudoaldosteronism type II mutations resemble the response to intravascular volume depletion (promotion of salt reabsorption without K(+) secretion), a condition that is associated with high angiotensin II (AngII) levels, it has been proposed that AngII signaling might affect WNK4 modulation of the NCC. In Xenopus laevis oocytes, WNK4 is required for modulation of NCC activity by AngII. To demonstrate that WNK4 is required in the AngII-mediated regulation of NCC in vivo, we used a total WNK4-knockout mouse strain (WNK4(-/-)). WNK4 mRNA and protein expression were absent in WNK4(-/-) mice, which exhibited a mild Gitelman-like syndrome, with normal blood pressure, increased plasma renin activity, and reduced NCC expression and phosphorylation at T-58. Immunohistochemistry revealed normal morphology of the distal convoluted tubule with reduced NCC expression. Low-salt diet or infusion of AngII for 4 d induced phosphorylation of STE20/SPS1-related proline/alanine-rich kinase (SPAK) and of NCC at S-383 and T-58, respectively, in WNK4(+/+) but not WNK4(-/-) mice. Thus, the absence of WNK4 in vivo precludes NCC and SPAK phosphorylation promoted by a low-salt diet or AngII infusion, suggesting that AngII action on the NCC occurs via a WNK4-SPAK-dependent signaling pathway. Additionally, stimulation of aldosterone secretion by AngII, but not by a high-K(+) diet, was impaired in WNK4(-/-) mice.

Indexed as

AldosteroneAngiotensin IIAnimalsBlood PressureDiet, Sodium-RestrictedDNA PrimersImmunoblottingImmunohistochemistryInfusion Pumps, ImplantableKidneyMiceMice, KnockoutPhosphorylationProtein Serine-Threonine KinasesPseudohypoaldosteronismReal-Time Polymerase Chain ReactionAldosteroneAngiotensin IIDNA PrimersProtein Serine-Threonine KinasesReninSodium Chloride SymportersStk39 protein, mouseWNK4 protein, XenopusXenopus Proteins

Identifiers

PMID22550170
PMCPMC3356635
OpenAlexW2039492547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.